You are here
Novartis signals growing ambitions for cancer therapies
NOVARTIS AG is pushing ahead with one of its most ambitious cancer therapies, a treatment that the Swiss drugmaker says has blockbuster potential as it extends that technology to a wider pool of tumour-ridden patients.
Europe's second-biggest drugmaker is planning to test
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org